#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoinflammation with infantile enterocolitis Cholangitis sclerosing Factor VIII deficiency Autologous haematopoietic stem cell transplant Juvenile idiopathic arthritis Haemolytic uraemic syndrome B-cell type acute leukaemia Type IIa hyperlipidaemia Fungal infection Alternating hemiplegia of childhood Burkitt's lymphoma refractory Peritoneal mesothelioma malignant Amyotrophic lateral sclerosis gene carrier Scedosporium infection Precursor T-lymphoblastic lymphoma/leukaemia recurrent More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Treatment Sarcoidosis – Trials in Disease Basal cell naevus syndrome – Trials in Disease Hereditary angioedema – Trials in Disease Indolent systemic mastocytosis Pelizaeus-Merzbacher disease – Diagnostics Myelodysplastic syndrome with excess blasts – Basic Information Factor VIII deficiency – Treatment Ewing’s sarcoma recurrent – Trials in Disease Haemolytic uraemic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trimetazidine Dihydrochloride Regn7075 Izorlisib Mesilate Ponsegromab Alectinib Hydrochloride Sacubitril Nedosiran Anidulafungin Dasiglucagon Amiloride Ademetionine Crgd-Zw800-1 Vinorelbine Tartrate Omp66 Mosaic Hbcoreag Nalbuphine Hydrochloride Cldn6 Rna-Lpx A/H1N1 INFLUENZA VACCINE Leniolisib Phosphate Zinc Oxide More therapies…

    Learn about Your Condition

    Hypersensitivity Rhinitis allergic Glomerulonephritis acute Chondropathy Keratosis follicular Thymoma malignant Colorectal cancer stage IV Proteus syndrome Pain Endolymphatic hydrops Exfoliation glaucoma Erdheim-Chester disease Hypertonic bladder Affective disorder Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Precursor T-lymphoblastic lymphoma/leukaemia recurrent

  • Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

    Recruiting

    3 1 1
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study on the Safety and Effectiveness of OC-1 Therapy for Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Precursor B-lymphoblastic lymphoma recurrent
    Investigated Drugs:
    • Ruxolitinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor B-lymphoblastic lymphoma recurrent
    • Precursor B-lymphoblastic lymphoma refractory
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    Investigated Drugs:
    • Trametinib
    Austria Belgium Denmark Finland France Germany +5

  • Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Precursor B-lymphoblastic lymphoma recurrent
    Investigated Drugs:
    • Dasatinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!